GREASE II. A phase II randomized, 12-month, parallel-group, superiority study to evaluate the efficacy of a Modified Atkins Diet in Autosomal Dominant Polycystic Kidney Disease patients-Reference-Cited by-同舟云学术

GREASE II. A phase II randomized, 12-month, parallel-group, superiority study to evaluate the efficacy of a Modified Atkins Diet in Autosomal Dominant Polycystic Kidney Disease patients

Published:2020-09 Issue: Volume:13 Page:100206
ISSN:2213-4344
Container-title:PharmaNutrition
language:en
Short-container-title:PharmaNutrition

Author:

Testa Francesca,Marchiò Maddalena,D’Amico Roberto,Giovanella Silvia,Ligabue Giulia,Fontana Francesco,Alfano Gaetano,Cappelli Gianni,Biagini Giuseppe,Magistroni Riccardo

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology,Food Science

Reference59 articles.

1. Autosomal dominant polycystic kidney disease;Cornec-Le Gall;Lancet,2019

2. The European Renal Association - European Dialysis and Transplant Association Registry Annual Report 2014: a summary;Pippias;Clin. Kidney J.,2017

3. ADPKD current management and ongoing trials;Testa;J. Nephrol.,2019

4. Tolvaptan in patients with autosomal dominant polycystic kidney disease;Torres;N. Engl. J. Med.,2012

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ketogenic Interventions in Autosomal Dominant Polycystic Kidney Disease: A Comprehensive Review of Current Evidence;Nutrients;2024-08-13

2. Potential Add-On Benefits of Dietary Intervention in the Treatment of Autosomal Dominant Polycystic Kidney Disease;Nutrients;2024-08-06

3. Investigational agents for autosomal dominant polycystic kidney disease: preclinical and early phase study insights;Expert Opinion on Investigational Drugs;2024-04-21

4. Diet and Physical Activity in Adult Dominant Polycystic Kidney Disease: A Review of the Literature;Nutrients;2023-06-03

5. Nonpharmacological Management of Autosomal Dominant Polycystic Kidney Disease;Advances in Kidney Disease and Health;2023-05